Church & Dwight (CHD) Q4 & Analyst Day 2026 earnings summary

Executive summary

• Achieved 1.6% net sales growth and 3.9% Q4 sales growth in 2025, with organic sales up 0.7% and strong contributions from Touchland and core brands.

• Adjusted EPS for 2025 rose 2.6% to $3.53, with Q4 EPS at $0.86, up 12% year-over-year; cash from operations reached $1.215 billion.

• Portfolio reshaping included divesting vitamins, Spinbrush, and VMS, and acquiring Touchland, with exits from Flawless and shower heads.

• Four of eight power brands grew share, with Hero and TheraBreath posting double-digit growth globally.

• $900 million returned to shareholders and a 4.2% dividend increase marked 30 consecutive years of increases.

Financial highlights

• Q4 2025 net sales grew 3.9% year-over-year; full-year net sales were $6.2 billion, with 77% domestic, 18% international, and 5% specialty products.

• Adjusted gross margin for Q4 was 45.5%, up 90 bps; full-year gross margin held steady at 45.2%.

• Free cash flow conversion was 127% in 2025, with a 10-year average of 119%.

• Debt/EBITDA ratio maintained at 1.5x–1.6x, with total debt at $2.2 billion and cash-on-hand at $409 million.

• Marketing investment at 11% of sales, in line with the Evergreen Model.

Outlook and guidance

• 2026 organic sales growth expected at 3%–4%, with reported sales flat to down 1.5% due to $400 million in business exits.

• Adjusted EPS expected to grow 5%–8% in 2026; cash flow guidance is $1.15 billion.

• Adjusted gross margin projected to expand by 100 bps, driven by portfolio changes and productivity.

• U.S. business projected to grow 3%, international 8%, and specialty products 5% in 2026.

• Continued focus on power brands, innovation, and international expansion.